The [current] system [of licensing medicines] was created to deal with traditional medicine which ais to prevent, detect, cure, or mitigate diseases. In this framework, there is no room for enhancing medicine. For example, drug companies could find it difficult to get regulatory approval for a pharmaceutical whose sole use is to improve cognitive functioning … Continue reading Nick Bostrom and Rebecca Roache